Chatterjee, Satabdi
Walker, David
Kimura, Tomomi
Aparasu, Rajender R.
Funding for this research was provided by:
Astellas Pharma US
Article History
Accepted: 7 January 2021
First Online: 8 March 2021
Declarations
:
: This study was funded by Astellas Pharma. Medical writing/editorial support was provided by Meagan Harwood from Broadstreet HEOR and funded by the study sponsor.
: David Walker and Tomomi Kimura are employees of Astellas and may own Astellas stock. Rajender Aparasu reports grants from Incyte and Novartis, outside the submitted work. Satabdi Chatterjee has no conflicts of interest to declare.
: This study was approved under exempt category by the University of Houston Committee for the Protection of Human Subjects.
: Not applicable.
: Not applicable.
: Data are not available due to the CMS data use restrictions for research identifiable files.
: Not applicable.
: All authors contributed to the study conception and design, writing of the manuscript, and read and approved the final manuscript. Data analysis was performed by Satabdi Chatterjee and Rajender Aparasu.